This paper compares batch and continuous technologies in terms of product quality and process performance in pharmaceutical tablet manufacturing using ethenzamide as the active pharmaceutical ingredient. Batch and continuous processes using wet granulation were investigated by performing experiments on the scale of 5 and up to 100 kg/lot, using the same raw materials. Three technologies were tested and compared: (i) batch technology using fluidized bed granulation, (ii) batch technology using high shear granulation, (iii) continuous technology using high shear granulation. In the full-scale experiment, in all three technologies including continuous technology, the quality of the tablets fulfilled the target values regarding hardness, active pharmaceutical ingredient content, and dissolution. The granules produced by different technologies, however, presented varying attributes regarding granule size distribution, loose bulk density, or scanning electron microscope images. The process performance, more specifically the yield, was slightly better for batch technologies than for the continuous technology, mainly due to losses in the start-up operation. Notably, this study has shown that continuous technology, which is generally believed to not entail scale-up procedures, could in fact, require parameter adjustment for prolonged operation. The results provided suggestions for improvements to implement large-scale continuous technologies in the pharmaceutical industry.
Introduction
In the pharmaceutical industry, continuous manufacturing has become a realistic alternative to conventional batch manufacturing to increase process agility and flexibility (Lee et al., 2015) . Continuous technology is believed to have the merits of (i) flexible change in production quantities and (ii) ease of scale-up, which are important in commercial manufacturing. The most advanced application of continuous manufacturing technology in the pharmaceutical industry is found in the production of solid drugs such as tablets (Ierapetritou et al., 2016) . In July 2015, the US Food and Drug Administration (FDA) approved the commercial application of continuous technology in a Vertex production line of Orkambi®. The development of process analytical technology (PAT), the online monitoring technology for process control, has been the key contributor, as reviewed by Fonteyne et al. (2015) . Besides solid drug products, the application scope of continuous technology is expanding to active pharmaceutical ingredients (API) of small molecules (e.g., Jolliffe et al., 2018) and biopharmaceuticals (e.g., Walther et al., 2015; Hummel et al., 2018) .
Toward actual implementation of the continuous technology, the relationship between the input parameters of continuous technology and product quality has been investigated through experiments and simulation. Ervasti et al. (2015) and Wang et al. (2017) described the effects of the physical properties of raw materials and process parameters on product quality in direct compression manufacturing. Kumar et al. (2014) assessed the effects of process parameters on the characteristics of mixing and transport in continuous wet granulation. Meng et al. (2017 Meng et al. ( , 2016 analyzed the critical process parameters to granules' properties in a wet granulation process using continuous high shear and twin screw granulators. Different unit operations have been experimentally studied for the development of PAT, e.g., compression (Wahl et al., 2014) , roller compaction (Austin et al., 2013) , and wet granulation (Kumar et al., 2015; Zomer et al., 2018) . Singh et al. (2014) proposed a hybrid model predictive control-proportional integral derivative (MPC-PID) control system using PAT for continuous direct compression. As to the simulation work, Metta et al. (2018) used the discrete element method-population balance model as the mechanism for estimating physical properties of the products from milling. In addition, flowsheet models of the continuous tablet manufacturing processes were presented for process development and challenge identification (e.g., Boukouvala et al., 2012; García-Muñoz et al., 2018) . Furthermore, a number of studies have been performed on residence time distribution for process stability investigations (Kruisz et al., 2017; Mangal and Kleinebudde, 2017; Martinetz et al., 2018) .
To assess the impact of the shift from batch to continuous technologies, previous studies presented comparative studies of these two technologies regarding cost and product quality. Schaber et al. (2011) compared the production cost of batch and continuous tablet manufacturing processes starting from an API. Matsunami et al. (2018a) developed a model that can evaluate the net present cost after a product launch for a systematic comparison of the technologies. With respect to product quality, Lee et al. (2013) compared batch high shear and continuous twin screw granulators in simple conditions where one type of ingredient and small laboratory-scale granulators were applied. Beer et al. (2014) compared product quality of these two granulators using multiple ingredients and larger laboratory-scale granulators such as 5 kg/lot. Also, Järvinen et al. (2015) performed laboratory-scale experiments, e.g., at 500 g/lot, and compared the quality of granules and tablets produced by batch fluidized bed, high shear, and continuous high shear granulators. However, process understanding at industrial scale is still missing, which is required to guide process design activities for continuous technologies.
In this work, we present a comparison of the batch and continuous technologies for pharmaceutical tablet manufacturing based on largescale experiments using ethenzamide. The process using wet granulation was investigated by first performing 5-10 kg-scale experiments followed by 100 kg-scale experiments; in all experiments, the same raw material was used. Three technologies were tested and compared: (i) batch technology using fluidized bed granulation, (ii) batch technology using high shear granulation, and (iii) continuous technology using high shear granulation. In the experiments, the physical properties of the produced granules and tablets were measured along with product yield, and causes for product losses were analyzed. The results were summarized to assess and compare product quality and process performance, and also to guide further the improvement and implementation of the industrial-scale continuous technology. An earlier version of this work was presented at the 28th European Symposium on Computer-Aided Process Engineering (Matsunami et al., 2018b) .
Materials and methods

Materials
The formulation of the tablets produced in the experiments is presented in Table 1 . Ethenzamide (supplied by Iwaki Seiyaku Co. Ltd., Tokyo, Japan), which is normally used as an antipyretic, analgesic, or anti-inflammatory agent (Iwaki Seiyaku Co., Ltd. official webpage, 2017), was used as the API. D-Mannitol (supplied by Mitsubishi Shoji Foodtech Co., Ltd., Tokyo, Japan) and microcrystalline cellulose (UF-702, by Asahi Kasei Corporation, Tokyo, Japan) were used as the excipients. Hydroxypropyl cellulose (HPC-L, Nippon Soda Co., Ltd., Tokyo, Japan) was used as the binder with ion-exchanged water (Shimadzu Corporation, Hyogo, Japan) as the solvent to provide the 7.0 wt % aqueous binder solution (binder-aq) to the process. Binder-aq was formulated by mixing the binder into ion-exchanged water in a tank at room temperature. The ratio of the binder-aq to the raw material quantity consisting of the API and excipients was set to 22 wt%. Magnesium stearate (Taihei Chemical Industrial Co., Ltd., Tokyo, Japan) was used as the lubricant. These compounds were chosen because of their availability for the large-scale experiments as well as their wide application in the pharmaceutical industry.
Materials and formulations used in this study represent a common combination within the Japanese pharmaceutical industry. The solubility and the content of ethenzamide used in our study were 0.034 g/L and 29.4 wt%, respectively. These values are in the range of those previously tested in literature. Table 2 summarizes the type and the content of the used materials as well as the specifications of the machine/process in previous studies. Fig. 1 shows the overview of used APIs with respect to their solubility and content in experimental runs in literature. Solubility data for ethenzamide was extracted from Khatioda et al. (2017) , and for all other APIs from DrugBank database (DrugBank, 2018; Wishart et al., 2018) . It can be seen from Fig. 1 Matsunami et al. International Journal of Pharmaceutics 559 (2019) 210-219 
Manufacturing methods
The investigated process, consisting of mixing, wet granulation, drying, milling, blending, and compression units, together with the compared technologies are shown in Fig. 2 . Wet granulation was adopted because of its relevance to the industry especially in Japan, where small tablet sizes are often required.
Regarding the equipment scale, the initial experiment (Experiment 1) was conducted at scales from 5 to 10 kg/lot, and the full-scale experiment (Experiment 2) was performed at the scale of 100 kg/lot. The aim of Experiment 1 was to obtain and confirm feasible process parameters before conducting Experiment 2, whereas that of Experiment 2 was to perform the final assessment of product quality and process performance. Because the same raw material was used at both experimental scales, the effect of scale-up in each technology could be analyzed from the results of Experiments 1 and 2. The lot sizes were determined differently in batch and continuous runs because of the difference in manufacturing systems between the technologies. In batch technology, the size of the granulator was equal to the lot size, whereas in continuous technology, a fixed rate of 25 kg/h was applied and thus the continuous running time determined the lot size.
The equipment specifications for the three technologies are given in the following sections. The compression machine 102i (Fette Compacting, Hyogo, Japan) was used in the compression in all technologies. Main compression and pre-compression forces were 5.8-6.2 N and 1.6-1.8 N, respectively; the number of the set of punches, rotation speed, and dwell time were 30, 77 min −1 , and 8.2 ms, respectively.
Batch technology: fluidized bed granulation
Fluidized bed granulators were used for the mixing, granulation, and drying units. GPCG-15CT (Powrex Corporation, Hyogo, Japan) was used with 10 kg of raw materials in Experiment 1; GPCG-120 (Powrex) was used with 100 kg of raw materials in Experiment 2. The detailed process parameters applied to the fluidized bed granulation are presented in Table 3 . Some of the process parameters were changed from Experiment 1 to 2 because of scale-up, e.g., air inlet flow was adjusted to maintain the linear velocity of the inlet air. Milling was not applied because the size distribution of the granules produced by fluidized bed Table 2 Review of materials used for experiments of continuous wet granulation in previous studies. Summary of the solubility of used APIs and API content in our and previous studies and this work. Reference numbers are used for labeling data points (see Table 2 for experimental details).
granulation is known to be narrow enough to not require further milling. The blending process was performed manually in Experiment 1, and by a blender (FM-W-75 V, Fujisangyo Co., Ltd., Yamaguchi, Japan) in Experiment 2. In Experiment 2, only 20 kg granules out of 100 kg were further processed to produce tablets by blending and compression because of the size constraints of the blender.
Batch technology: high shear granulation
High shear granulators were used for the mixing and granulation units. VG-25 (Powrex) was used with 5 kg of raw materials in Experiment 1, and VG-400 (Powrex) was used with 100 kg of raw materials in Experiment 2. The detailed process parameters applied to batch high shear granulation are presented in Table 4 . As in the fluidized bed granulation, the parameters were determined based on scaleup laws. One example of blade rotation speed is shown in Eq. (1) -] represent the blade rotation speed at scale i and j, the outer diameter of the blade at scale i and j, and the scale-up coefficient, respectively. The values of k depend on the strategy of the scale-up, e.g., k = 1 for making the peripheral velocity of the blade tip constant, or k = 0.5 for making the centrifugal force of the blade tip constant. In this study, k = 0.67 was adopted. For the drying unit, MP-01 (Powrex) was used in Experiment 1, and GPCG-120 (Powrex) was used in Experiment 2. In both Experiment 1 and 2, Comil QC197S (Quadro Engineering, Ontario, Canada) was used for the milling unit. The specifications of the blending unit were the same as for the fluidized bed granulation. For the same reason as batch fluidized bed granulation, only 20 kg granules out of 100 kg were further processed to produce tablets by blending and compression in Experiment 2.
Continuous technology: high shear granulation
For the mixing unit, VG-25 (also by Powrex) was used in Experiment 1, and VG-400 (Powrex) was used in Experiment 2. In both experiments, the mixing unit was used offline. The pre-mixed powder raw material and the binder-aq were transferred to the material feeder (KT35, Coperion K-Tron, Sewell NJ, USA) and the binder feeder (520S, Watson Marlow, Cornwall, UK), respectively. For the granulation and drying units, CTS-MiGRA-CM (Powrex) was used, which is a combination of a continuous high shear granulator (MiGRA-CM-MG100) and a semi-continuous fluidized bed dryer (MiGRA-CM-FD01W). The granulator has one center blade (not twin screw) with a scraper. The dryer consists of four vessels, which perform loading, drying, and discharging in a moving sequence across the vessels. The cycle time of the discharge from a vessel depends on the termination point of drying. Overall, CTSMiGRA-CM continuously produces and dries granules from the premixed powder raw material. Table 5 shows the detailed process parameters applied to continuous high shear granulation; the rotation speed of the blade was varied from Experiment 1 to 2 to reduce the mechanical vibration of the granulator (for details, see Sections 3.2 and 3.4). Inlet air volume and temperature of the dryer were 1.2-1.4 m 3 / min and 87°C, respectively. After drying, Comil U-10 (Quadro) was used as the milling unit in order to avoid large particles. The milled granules were stored in a hopper and then fed to the blender. The blending of the granules and lubricant was performed before compression, manually in Experiment 1, and by a continuous blender (MiGRA-CM-MG100) with a blade (1000 rpm) and a scraper (20 rpm) in Experiment 2. In Experiment 1, granulation, drying, and milling were interconnected while the other units of mixing, blending, and compression were conducted individually. The transport from milling to blending, and further to compression was performed manually. In Experiment 2, all units except for the initial mixing were interconnected and conducted fully continuously. The transportation between feeder to granulator, storage hopper to blender, and blender to compression was fulfilled by the gravitational force. Pneumatic transportation was used from the granulator to the dryer, and further to the storage hopper. The minimum quantities of the raw materials to be processed were set as 5 kg and 100 kg as one lot for Experiments 1 and 2, respectively. In both experiments, additional time [min] was planned considering the startup time until a stable operation is reached. Matsunami et al. International Journal of Pharmaceutics 559 (2019) 210-219 In Experiment 2, the units up to the dryer were first filled with materials. During this filling process, the initially produced granules for start-up time ( = 2 min) were discharged at the rate of 25 kg/h without being fed to the dryer. The count of the continuous running time started when the granules from the dryer passed the inline monitoring device installed between milling and blending. This device, Parsum IPP 70 (Parsum GmbH, Sachsen, Germany), measured size distribution of the dried granules in a real-time manner (recorded every 5 sec). The continuous facilities used in the experiment had no automated control system, such as MPC or PID controllers. As mentioned earlier, the drying unit has four vessels. The discharge of the first vessel took around 7-8 min during which various preparation steps were done at the line. From the second vessel on, the discharge had an average cycle time of 3.05 min with a standard deviation of 0.58 min. The process was ended at 4 h and = 10.5 min, and the materials remaining in the machine, e.g., raw material powder in the feeder, were collected as the loss.
In Experiment 2, the start of the production was retrospectively determined by investigating the temporal change of the granule size distribution. After performing the production, the measurement data of Parsum IPP 70 were used to calculate the volume-based mean of the size distribution for each discharge cycle of the dryer. For the first cycle, the measured data was available until 4.5 min, which covered most of the granules from the first vessel. From the second cycle on, the mean value was obtained at the end of the cycle. Based on the temporal change, the cycle was determined when the mean of the granule size was within one standard deviation range of the mean values; this cycle was judged as the start of the production, which was used for the process performance evaluation.
Perturbation of the feed has not been investigated in this work since wet granulation was used where the feed is already pre-mixed. This aspect becomes more relevant as direct compaction is applied as shown by previous studies, e.g. Singh et al (2014) .
The last two columns of Table 2 summarize the types of continuous wet granulators and manufacturing rates in the previous studies. This work studies the impact of extended operation of one of the main types of granulators used in industry (high shear). The granulator was run at the highest rate found in the literature (25 kg/h), which is regarded as a standard for the commercial production in the pharmaceutical industry. This work thus serves as the first attempt to understand full scale operation of a relevant continuous technology.
Characterization of product quality and process performance
The quality attributes and the yield were assessed by sampling granules and tablets during or after the manufacturing process. The results of Experiment 2 were used for the final technology comparison; the results of Experiments 1 and 2 were used for analyzing the effects of scale-up.
Granules
Granule samples were taken from the milling unit in both batch and continuous high shear granulation cases, and from the drying unit in case of batch fluidized bed granulation. To characterize the produced granules, sieves (Seishin Enterprise Co. Ltd., Tokyo, Japan) were applied to obtain the particle size distribution and to calculate the volume-based mean diameter and geometric standard deviation. In this paper, the mean diameter and the standard deviation are always based on the volume. In addition to this offline measurement of the sampled granules, the aforementioned Parsum IPP 70 was applied to the continuous technology in Experiment 2. The loose bulk density and the water content were measured by a moisture analyzer (Sartorius MA150, Göttingen, Germany). Images of the granules were obtained by a scanning electron microscope (SEM, Jeol Ltd., Tokyo, Japan).
Tablets
To analyze tablet properties, ten units were sampled in each run of an experiment. Tablet weight was measured by an electronic balance (Shimadzu Corporation, Kyoto, Japan). In addition, tablet size and the hardness of the ten units were measured by a tablet hardness tester (ERWEKA Gmbh, Heusenstamm, Germany). A dissolution test was conducted by additionally sampling six tablets and using a dissolution testing machine (Fuji-Sangyo Co., Ltd., Tokyo, Japan) for 180 min based on the Japanese Pharmacopeia (MHLW, 2016) . During the dissolution test, the values of %-API dissolved were measured at 15 timepoints, where eight timepoints were within the first 30 min. In Experiment 2, the API content was measured together with the dissolution, and the mean API content and content uniformity were calculated. The latter was expressed using the coefficient of variation. During the operation, the tablet weight, size, and hardness were measured by sampling tablets every 20 min, but content uniformity was not measured. It was reasonable to assume the uniformity because the raw materials were pre-mixed before the compression. For the continuous technology, tablets were sampled every hour for the dissolution test to observe the temporal stability of the product quality.
The following targets were defined to judge the quality of the tablets produced in different technologies: (i) the tablet hardness should be greater than 40 N, (ii) the API content should be between 95% and 105% of the target composition, i.e., 29.4 wt% (See Table 1 ), and (iii) dissolution (i.e., %-API dissolved) should be greater than 80% within 30 min. These values were defined as typical targets based on the industrial expert knowledge of the authors.
As an indicator for the comparison of technologies, a so-called similarity factor f 2 [-] was used, which is defined in Eq. (2):
where the parameters n [-], R t [%], and T t [%] represent the number of time points, the dissolution of the reference product and of the test product at time t, respectively (FDA, 1997). Two dissolution profiles are regarded as equivalent if the value of f 2 is larger than 50. The factor f 2 was used to compare different technologies within the same scale or different scales within the same technology. Regarding the time scale used for calculating f 2 , 30 (eight timepoints) and 180 (15 timepoints) min were adopted to cover the different time ranges of dissolution at different scales and used technologies.
Process performance
The yield was determined by analyzing the quantity of final product and the losses such as powders sticking to the surface of the granulator. The final product was defined as the tablets produced in the stabilized process. The tablets produced during the start-up operation in continuous technology as well as during the initial condition setting of compression were regarded as a loss. In the experiment, the quantity of the product and the losses were measured for each piece of equipment; the uncertain losses such as powders passing through the bag filter of the fluidized bed granulator/dryer, or the remaining powder in the machine in continuous technology were estimated based on the mass balance. The measured residual water content of the granules and tablets after drying was very small (less than 0.5 wt%, as presented in Table 6 in the results section) and was therefore neglected in the [kg/lot] represent the quantity of granules produced after drying in the batch fluidized bed granulation or milling in batch high shear granulation, the quantity of granules fed to blending, and the quantity of the final product, respectively. Eq. (3) was determined on the assumption that the loss in the compression unit was the same regardless of the production scale. This assumption is based on the knowledge that the main cause of loss in compression is the initial condition setting/fine tuning, which is scale-independent. The presence of the adjustment factor 
In order to be consistent with batch technology, the sum of the values for m API , m excipient1 , and m excipient2 was set as 100 kg. This corresponds to the quantity of the powder raw materials fed to the granulator for 4 h including the initial = 2 min. The corresponding values of m binder and m lubricant were calculated using Table 1 . The value for m tablets was the mass of the final product.
Results and discussion
Characterization results of granules
SEM images of the granules produced in Experiment 2 are shown in Fig. 3 . In batch technology, the granules produced by fluidized bed granulation were porous, and those produced by high shear granulation were spherical. This tendency is in agreement with conventional knowledge. The granules produced by continuous technology presented a similar shape to those produced by batch high shear granulation, probably because of the similarity in granulation mechanism. The characterization results of the granules' properties are shown in Table 6 , and the granule size distribution in Experiment 2 is shown in Fig. 4 . Both results were obtained offline by the aforementioned sieves. While the mean diameter in continuous technology was larger than in batch technologies, the geometric standard deviation (see (b) and (c) of Experiment 2 in Table 6 ) and particle size distribution (see Fig. 4 ) in continuous technology resembled that in batch high shear granulation. Scott et al. (2000) showed that the granules produced by batch high shear granulation tend to have a bimodal particle size distribution. This tendency was also observed in this experiment, and more remarkably, the bimodal tendency was observed in continuous high shear granulation as well. Compared to batch high shear granulation, continuous high shear granulation yielded higher frequency of larger particles (500-1000 µm, see Fig. 4 ). This result could be due to the difference in the homogeneity of dispersion and/or in the degree of agglomeration in the granulation unit. The water content after drying was shown to be very small with no significant differences between the technologies and scales (as seen in Table 6 ).
Characterization results of tablets
The characterization results of the tablets' physical properties are shown in Table 7 . The mean and coefficient of variation values are reported in the table. All tablets in Experiment 2 achieved the aforementioned targets regarding hardness and API content, i.e., the acceptability of the products was confirmed also in continuous technology. Among the manufacturing technologies, the tablet hardness in batch high shear granulation was the lowest. The API content was the lowest in batch fluidized bed granulation. The cause of the difference in API content was assumed to be that the powders containing high-concentration API passed through the bag filter in fluidized bed granulation. Fig. 5 compares the dissolution profiles in Experiment 2, where all the tablets fulfilled the aforementioned target, i.e., dissolution was greater than 80% within 30 min. As shown in Table 8 , all values of f 2 were larger than 60, which confirmed the capability of all manufacturing technologies, including continuous, at an industrial scale.
Further findings were obtained regarding scale-up. The dissolution profiles between Experiments 1 and 2 are compared in Fig. 6 . Although all technologies even in Experiment 1 achieved the dissolution target, some profiles have changed from Experiment 1 to 2. The values of f 2 between Experiments 1 and 2 for each technology are presented in Table 9 . Experiment 1 is used for calculation of R t and Experiment 2 for T t . In batch fluidized bed granulation, f 2 was greater than 50 (see Fig. 6 (a) and the second row of Table 9 ), whereas in batch high shear and continuous high shear granulation technologies, f 2 was lower than 50 (see Fig. 6(b, c) and the third and fourth rows of Table 9 , respectively). For batch technology, the matured knowledge for scale-up was provided by the industrial co-authors, and was used in the experiment; however, the dissolution in the two scales was different. In continuous technology, the same equipment was used for the core units of granulation and drying in both Experiments 1 and 2; however, the scale-up Fig. 3 . SEM images of the granules produced in Experiment 2.
K. Matsunami et al. International Journal of Pharmaceutics 559 (2019) [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] was not straightforward. When Experiment 2 was conducted for the first time, all conditions were specified the same as in Experiment 1 except the minimum running time (changed from 12 min to 4 h). However, such runs could not be completed due to equipment clogging and subsequent malfunction. Completion of the 4 h-operation in Experiment 2 required three additional adjustments: the ratio of binderaq, the blade rotation speed, and the specification of the screw in the kneading part of the granulator (details to be presented in Section 3.4). In order to maintain the consistency of tablet formulation and compensate for the reduced binder-aq ratio in the granulation, the corresponding mass of the binder powder was added in mixing step. The 4 hoperation could be completed after three attempts, and the results at the final (third) run were used for the characterization of the scaled-up process. To assess the effect of the abovementioned three changes in continuous technology, the results of Experiment 1 and 2 were compared (see Table 7 and Fig. 6 ). One critical point is the tablet hardness, which decreased from 85 N to 65 N. Potential reasons for this decrease could be the reduced water content in the granulation step as well as the reduced rotation speed and the altered shape of the screw. The three changes might have also led to the change in the dissolution profile as shown in Fig. 6 . This experiment was an actual case where the scale-up, which is believed to be easy in continuous technology, was not straightforward. Table 10 summarizes yield and breakdowns of loss causes calculated based on Eqs. (3) and (4). The yield was more than 93% in both batch technologies but was lower in continuous technology. In batch technology, the major causes of loss were material sticking to the granulator and the condition setting of compression regardless of the granulation technology. In contrast, in continuous technology, the major causes of loss were residues in the feeder and loss during the start-up of the process, which are specific to this technology. "Other causes through the entire process in continuous technology" accounts for the remaining powder in the machine, which was estimated based on the mass balance. Condition setting of compression was commonly an important contributor to material loss. The material lost during condition setting was the largest in continuous technology. However, this is a process Fig. 4 . Granule size distribution in Experiment 2 (measured offline by sieves).
Characterization results of the process
Table 6
Physical properties of granules for (a) batch (fluidized bed), (b) batch (high shear), and (c) continuous (high shear). The mean diameter and standard deviation were measured offline by sieves. Two dissolution profiles are judged the same if f 2 is larger than 50.
K. Matsunami et al. International Journal of Pharmaceutics 559 (2019) 210-219 where operators were less trained and happened to face difficulties in switching the mode from condition setting to production. This value is expected to improve with further training and operation. Nevertheless, the overall yield in the continuous technology run was the lowest even if the mass lost during compression condition setting is excluded from the calculation. A further investigation was performed on the dynamic variation of the mean granule diameter monitored in continuous technology. Fig. 7 shows the temporal profile of the mean at the end of each discharge cycle of the dryer, with indicating the overall mean, µ [μm] , and the standard deviation of the mean values, [μm] . The first point, i.e., the mean value for the first cycle was calculated by the measured data until 4.5 min. Here, the presence of large particles is indicated. We suspect that this was because water diffusion and powder dispersion were not homogenous within the mixture, which led to a larger mean diameter. The second point is within the one standard deviation range, and afterwards the reported values were stable. Thus, the start of the production was determined as the second discharge of the dryer. The total loss quantity in the start-up, i.e., the initial discharge of granules for 2 min ( ) and the first discharge of the dryer, was 2.08 kg. This corresponded to the decrease of 2.04% of the yield (see Table 10 ). Fig. 8 compares the dissolution profiles of the tablets at different continuous running times together with the values of f 2 at 180 min. Here, the reference product in Eq. (2) was set as the one used for creating the dissolution profile of continuous technology in Experiment 2 (see Figs. 5 and 6(c) ). The first sample was taken when the condition setting in compression was completed; afterwards, samples were taken every hour, which are the reported hours in Fig. 8 . The values of f 2 Fig. 6 . Comparison of dissolution profiles in Experiments 1 and 2 in each technology.
Table 9
The values of f 2 between Experiments 1 and 2. Experiment 1 is used for calculation of R t and Experiment 2 for T t . Two dissolution profiles are judged the same if f 2 is larger than 50.
Table 10
Yield and breakdown of the causes of loss. confirm that the dissolution was highly stable over the entire run. These findings indicated that stabilizing the start-up operation was an improvement opportunity for continuous technology to increase yield and thus to become economically more competitive. The implementation of PAT to the process might help in this regard. As far as the monitoring results in Experiment 2 suggest (see Figs. 7 and 8) , it is possible to maintain product quality once the process becomes stable. However, ensuring a smooth and long running of the process is an important challenge, as seen from the fact that the condition in Experiment 1 could not be directly applied to Experiment 2.
Scale-up issues of continuous technology
Out of the three runs in Experiment 2, the first and the second runs failed due to the same reason, i.e., the inlet tube that provided the binder-aq to the kneading part of the granulator was clogged and detached. In the first run, all conditions were set the same as in Experiment 1 except the minimum running time. In the second run, the blade rotation speed was reduced from 6000 to 5000 rpm; also, the ratio of binder-aq was decreased from 22 wt% and 18 wt%. In the third run, the type and specification of the screw used for the kneading part was changed (for the details, see Fig. 9 ). The 4 h-operation was completed in the third run.
A root cause analysis was performed considering six major categories (e.g., Montgomery, 2009) of "machine," "method," "material," "personnel," "measurement," and "environment." Five possible causes were considered here. The first was the vibration of the granulator that could be classified as a machine-related cause. The second was the internal pressure of the materials in the kneading machine to the tube, as a material-related cause. The third was human error such as erroneous contact to the tube or inadequate assembly of the machine, as a personnel-related cause. The fourth was the attachment method of the tube as a method-related cause, and the last was unexpected events such as earthquake or blackout as an environment-related cause. We assume that the aforementioned three changes are related to the first two causes through the following mechanisms: (i) decrease of the blade rotation speed reduced machine vibration, (ii) reduction of the binderaq decreased the internal pressure to the tube and reduced clogging, and (iii) alteration of the screw decreased the internal pressure. There were no changes to machine assembly nor were there any recorded human errors or external environmental events within the experimental runs. Thus, we suspect that the unsuccessful full scale runs were due to the vibration of the machine and the internal pressure and clogging of the materials.
Conclusions and outlook
In this article, we presented the results of ethenzamide-based largescale experiments in tablet manufacturing processes where product quality and process performance were compared between batch and continuous technologies. The same raw material was used in three different technologies, with one employing continuous high shear granulation, and the experiments were performed first at a 5-10-kg/lot scale and then at a 100-kg/lot scale. The quality of the tablets fulfilled the target values regarding tablet hardness, API content, and dissolution in all three technologies, including continuous technology. The granules, however, showed differences in granule size distribution, loose bulk density, or SEM images among the technologies. The process performance, or more specifically yield, was found to be slightly better in batch technologies than in continuous technology, mainly as a result of the loss in the start-up operation. It was also observed that continuous technology, which is believed to require no special scale-up procedure, could necessitate parameter adjustment for full-scale production. Adjusted parameters could affect the final product quality, which needs to be carefully considered especially from a regulatory perspective. The work is innovative regarding the deepening of the understanding of large scale implementation of continuous technology in pharmaceutical manufacturing.
Some future improvement opportunities were identified for continuous technology. Seen from the analysis of yield, agile start-up operation was found as a relevant challenge. Yield is a critical factor in early research phases where the availability of the API is limited, and/ or in the case where expensive APIs are used. Further development and application of PAT could be valuable for earlier detection of the start of the stable operation phase, thus reducing start-up losses. Application of suitable control strategies could also mitigate the effect of perturbation propagation along the continuously operation production line. The balance between the installation and maintenance costs versus the benefits should be carefully considered.
Future work can include predictive monitoring for early failure detection within a continuously run operation. Operation data can be incorporated into machine learning algorithms for that purpose. Insights obtained from predictive monitoring can enhance process understanding for smoother operations. Another future direction is to go beyond working on a specific material, which was the case in our study. Recently, Van Snick et al. (2018) presented a multivariate database covering 55 pharmaceutical materials, where the materials were clustered by properties relevant to continuous manufacturing such as flowability. Such an overview of the material space would create new research opportunities, e.g., feasibility assessment of the materials for continuous manufacturing, which are vital for process design considering continuous technology.
Declarations of interest
None.
